Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-pbm
/
Psyence Biomedical Ltd
PBM
4.710
USD
+2.350
+99.58%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
105.51K
Market Cap
Loss
P/E TTM
Psyence Biomedical Ltd
4.710
+2.350
+99.58%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
Operating expenses
-31.11%
176.16K
205.24%
1.29M
--
255.73K
--
421.51K
R&D expenses
--
--
392.45%
790.89K
--
1.94K
--
160.60K
Other operating expenses
--
-8.54K
--
8.53K
--
--
--
--
Operating profit
31.11%
-176.16K
-205.24%
-1.29M
--
-255.73K
--
-421.51K
Net non-operating interest income (expenses)
Gains from sale of securities
-6771.05%
-105.58K
-632.09%
-9.90K
--
-1.54K
--
-1.35K
Other non-operating income (expenses)
--
-8.54K
--
8.53K
--
--
--
--
Income before tax
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Income after tax
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income from continuous operations
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income attributable to controlling interests
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Net income attributable to common shareholders
-24.09%
-318.21K
-204.59%
-1.29M
--
-256.43K
--
-422.70K
Basic earnings per share
-24.07%
-1.78
-204.56%
-7.21
--
-1.44
--
-2.37
Diluted earnings per share
-24.07%
-1.78
-204.56%
-7.21
--
-1.44
--
-2.37
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up